Graphics in video games have come a long way, and some developers made their game look like it takes place in a comic book.

GameSpot may get a commission from retail offers. Despite The Legend of Zelda: Wind Waker being one of the GameCube games appearing on Nintendo Switch Online when Switch 2 drops, that doesn't mean ...

Last week, Nintendo confirmed The Legend of Zelda: The Wind Waker would be sailing onto the Switch 2 as part of the GameCube library at launch. If you're worried this might rule out the Wii U HD ...

The GameCube library will be joining the Switch 2's online 'Expansion Pack' tier this June and one of three launch titles for this particular collection is Link's cel-shaded adventure The Legend ...

A sub-quest of the Cabana Deed sidequest, the hide-and-seek game with the kids that call themselves the Killer Bees nets you a Piece of Heart reward. To start the quest, go to the schoolhouse ...

A Nintendo exec has said the re-release of The Legend of Zelda: The Wind Waker on Switch 2 doesn’t mean Wind Waker HD will never be ported over. The original GameCube version of The Wind Waker was ...

Zelda fans, rejoice. While fans worldwide had many reasons to be optimistic about the Nintendo Switch 2, knowing three GameCube classics are arriving on launch day, including Wind Waker, there's still ...

Rejoice, Zelda fans. If you were disappointed by the possibility of the Wii U The Legend of Zelda: Wind Waker port potentially being scrapped due to the game's GameCube version inclusion via the ...

The title features a visual style of 3D character models with a cel-shading style in a comic book tone. The game is always in motion, with fairly fluid animations and no frame drops, making every ...

One of the titles named in the trailer was The Legend of Zelda The Wind Waker, which is an all-time classic. However, some people have been asking for the HD version of the game to come to the Switch ...

BCMA-directed cell therapy Carvykti (ciltacabtagene autoleucel) has seen sluggish growth since it was first approved by the FDA in March 2022 as a fifth-line or later therapy for multiple myeloma ...